News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gentiae Clinical Research Awarded Thorough QT Study By Biotech Industry Leader


8/9/2006 12:25:07 PM

Gentiae Clinical Research, Inc., the leader in comprehensive cardiac assessment services, announced today the commencement of a major $1.1M thorough QT study (TQT) on behalf of a Top 10 Biotech company.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES